Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 error instead of the study record.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now shows a 403 Forbidden error with standard site chrome, indicating access to the study record is blocked; visible content from the previous study details has been removed and replaced by the error notice.SummaryDifference17%

- Check56 days agoChange DetectedThe page revision tag changed from v3.6.6 to v3.7.0, indicating a software/template update. No study details or page navigation were altered.SummaryDifference0.1%

- Check70 days agoChange DetectedA new page revision entry added: v3.6.6, replacing the previous revision v3.6.5. This appears to be a minor backend/page metadata update and does not change study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.